Search research articles
Contact Us
Filters
Showing results (231-240 of 244) with videos related to
Page
of 25
Sort By:
Blood
|
February 14, 2018
Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin
Wei Jiang, Xiaoyan Zhou, Zengxia Li, et al.
Nature Chemistry
|
December 12, 2018
Rapamycin-inspired macrocycles with new target specificity
Zufeng Guo, Sam Y Hong, Jingxin Wang, et al.
Angewandte Chemie (International Ed. in English)
|
October 9, 2019
Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays
Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, et al.
Cell
|
May 11, 2022
PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease
Hyejin Park, Tae-In Kam, Hanjing Peng, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Rapaprotin is Activated by an Endopeptidase to Disassemble 26S Proteasome
Hanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Oncogene
|
August 3, 2021
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer
Yu Yan, Athira Narayan, Soonweng Cho, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial
Lauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Angewandte Chemie (International Ed. in English)
|
September 17, 2025
Rapaprotin, an Endopeptidase-Activated Proteasome Inhibitor that Induces 26S Disassembly
Hanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Journal of Pharmaceutical Analysis
|
July 13, 2023
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
Ping Zhu, Shi-You Li, Jin Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2013
Personalized chemotherapy profiling using cancer cell lines from selectable mice
Hirohiko Kamiyama, Sherri Rauenzahn, Joong Sup Shim, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 244) with videos related to
Sort By:
Page
of 25
Blood
|
February 14, 2018
Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin
Wei Jiang, Xiaoyan Zhou, Zengxia Li, et al.
Nature Chemistry
|
December 12, 2018
Rapamycin-inspired macrocycles with new target specificity
Zufeng Guo, Sam Y Hong, Jingxin Wang, et al.
Angewandte Chemie (International Ed. in English)
|
October 9, 2019
Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays
Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, et al.
Cell
|
May 11, 2022
PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease
Hyejin Park, Tae-In Kam, Hanjing Peng, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Rapaprotin is Activated by an Endopeptidase to Disassemble 26S Proteasome
Hanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Oncogene
|
August 3, 2021
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer
Yu Yan, Athira Narayan, Soonweng Cho, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial
Lauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Angewandte Chemie (International Ed. in English)
|
September 17, 2025
Rapaprotin, an Endopeptidase-Activated Proteasome Inhibitor that Induces 26S Disassembly
Hanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Journal of Pharmaceutical Analysis
|
July 13, 2023
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
Ping Zhu, Shi-You Li, Jin Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2013
Personalized chemotherapy profiling using cancer cell lines from selectable mice
Hirohiko Kamiyama, Sherri Rauenzahn, Joong Sup Shim, et al.
Page
of 25